The Aortic Aneurysm Market is witnessing significant growth driven by technological advancements, increasing prevalence, and evolving treatment paradigms. According to Market Research Future (MRFR), the market was valued at USD 6.366 Billion in 2024 and is projected to grow to USD 11.34 Billion by 2035, registering a CAGR of 5.39% during the forecast period of 2025–2035.
This growth is underpinned by rising awareness of cardiovascular diseases, innovations in minimally invasive surgical techniques, and expanding healthcare infrastructure across key global regions.
Market Segmentation and Insights
The Aortic Aneurysm Market can be segmented based on type, diagnosis method, treatment type, and end user, each of which presents unique opportunities and growth potential.
By Type
Abdominal Aortic Aneurysm (AAA): The largest market segment due to high prevalence in aging populations and established treatment protocols.
Thoracic Aortic Aneurysm (TAA): The fastest-growing segment fueled by advancements in minimally invasive surgeries and rising awareness.
Thoracoabdominal & Cervical Aneurysms: Niche segments with steady growth driven by clinical research and specialized treatments.
By Diagnosis Method
Ultrasound: Dominates the market owing to non-invasive procedures, cost-effectiveness, and widespread use.
CT Scan: Fastest-growing segment due to high-resolution imaging capabilities enabling precise diagnostics.
MRI & X-Ray: Specialized applications in complex aneurysm detection.
Angiography: Critical for detailed vascular insights but limited by invasiveness.
By Treatment Type
Endovascular Aneurysm Repair (EVAR): The most widely adopted minimally invasive procedure, offering shorter recovery times.
Surgical Repair: Traditional method for high-risk or complex cases, emerging with innovative techniques and robotic-assisted surgeries.
Medication & Monitoring: Supportive care options focusing on preventive management and disease progression.
By End User
Hospitals: Largest segment with comprehensive facilities for diagnosis and treatment.
Ambulatory Surgical Centers (ASCs): Fastest-growing segment due to efficiency, cost-effectiveness, and patient preference for outpatient procedures.
Diagnostic Laboratories & Specialty Clinics: Supporting early detection and follow-up care.
Regional Insights
Geographically, the North American Aortic Aneurysm Market leads with a valuation of USD 2.38 Billion, driven by advanced healthcare infrastructure and high prevalence of aneurysms. Europe follows at USD 1.45 Billion, supported by aging populations and technological adoption. Asia-Pacific is emerging rapidly (USD 1.02 Billion) due to increasing awareness, improving healthcare access, and investment in medical infrastructure. South America and MEA regions hold smaller shares but represent untapped potential for future growth.
[Explore the full report here : [https://www.marketresearchfuture.com/reports/aortic-aneurysm-market/companies]
Market Trends and Drivers
Technological Advancements in Treatment
The market is being transformed by innovations such as endovascular stent grafts, robotic-assisted surgeries, and advanced imaging tools. These technologies are improving surgical precision, reducing complications, and shortening recovery periods.
Increased Awareness and Screening
Growing public health initiatives are promoting awareness of risk factors like hypertension and smoking. Early detection through advanced imaging techniques is facilitating timely interventions, reducing mortality risks associated with aneurysms.
Focus on Personalized Medicine
Tailored treatment plans based on patient-specific risk profiles are enhancing therapeutic outcomes, driving demand for customized surgical devices and biologic therapies.
Rising Incidence of Aortic Aneurysms
With an estimated 200,000 new cases diagnosed annually, the growing prevalence among aging populations underscores the need for advanced treatment options and continuous monitoring solutions.
Expansion of Healthcare Infrastructure
Investment in healthcare facilities, particularly in emerging markets, is facilitating broader access to diagnostic and surgical services. Specialized vascular centers are increasing market penetration and enabling high-quality patient care.
Emerging Biologics and Pharmaceuticals
Research into targeted drugs and novel biologics aims to manage disease progression and enhance therapeutic efficacy, further contributing to market expansion.
Competitive Landscape
The Aortic Aneurysm Market features intense competition among key players such as:
Medtronic (US)
Abbott Laboratories (US)
Boston Scientific (US)
Terumo Corporation (JP)
Cook Medical (US)
Johnson & Johnson (US)
B. Braun Melsungen AG (DE)
Cardinal Health (US)
Stryker Corporation (US)
Recent industry developments include FDA approvals for Endurant II Stent Graft System, ALTO Abdominal Stent Graft, and GORE EXCLUDER Conformable AAA Endoprosthesis, highlighting innovation in minimally invasive treatments and enhanced patient outcomes.
Future Outlook
The Aortic Aneurysm Market is poised to continue its growth trajectory at a CAGR of 5.39% through 2035. Key opportunities include:
Development of next-generation minimally invasive surgical devices.
Expansion of telemedicine platforms for remote monitoring.
Integration of AI-driven diagnostic tools for early detection.
By 2035, the market is expected to witness substantial innovation and global expansion, driven by technological progress, increasing prevalence, and enhanced healthcare delivery across regions.
Related report :
